Chinese Journal of Physiology

ORIGINAL ARTICLE
Year
: 2019  |  Volume : 62  |  Issue : 5  |  Page : 210--216

The association of matrix metalloproteinas-2 promoter polymorphisms with lung cancer susceptibility in Taiwan


Guan-Liang Chen1, Shou-Cheng Wang3, Te-Chun Shen2, Chia-Wen Tsai2, Wen-Shin Chang2, Hsin-Ting Li2, Cheng-Nan Wu3, Che-Yi Chao4, Te-Chun Hsia2, Da-Tian Bau5 
1 Graduate Institute of Biomedical Sciences, China Medical University; Taichung Armed Forces General Hospital, Taichung; National Defense Medical Center, Taipei, Taiwan
2 Terry Fox Cancer Research Laboratory, Translational Medicine Research Center, China Medical University Hospital, Taichung, Taiwan
3 Department of Medical Laboratory Science and Biotechnology, Central Taiwan University of Science and Technology, Taichung, Taiwan
4 Department of Health and Nutrition Biotechnology, Asia University, Taichung, Taiwan
5 Graduate Institute of Biomedical Sciences, China Medical University; Terry Fox Cancer Research Laboratory, Translational Medicine Research Center, China Medical University Hospital; Department of Bioinformatics and Medical Engineering, Asia University, Taichung, Taiwan

Correspondence Address:
Dr. Da-Tian Bau
Translational Medicine Research Center, Terry Fox Cancer Research Laboratory, China Medical University Hospital, Taichung
Taiwan

Matrix metalloproteinases-2 (MMP2) has been reported to be overexpressed in various types of cancer. However, the contribution of various genotypes of MMP2 to lung cancer is controversial and not yet been examined in Taiwan. Therefore, in the current study, we investigated the association of MMP2 genotypes with lung cancer risk among Taiwanese. In this hospital-based, case–control study, 358 lung cancer patients and 716 age- and gender-matched healthy controls were recruited, and the genotypic distributions of MMP2-1306 and MMP2- 735 were determined. Then, their association with lung cancer was evaluated, and their interaction with personal smoking status was also examined via stratification analysis. The results showed that the percentages of variant CT and TT at MMP2-1306 were 17.3% and 1.7% among the lung cancer patients, respectively, much lower than those of 28.7% and 2.4%, respectively, among the healthy controls (P for trend = 0.0001). The allelic frequency distribution analysis showed that the variant T allele at MMP2-1306 conferred a statistically significantly lower lung cancer risk than the wild-type C allele (adjusted odds ratio = 0.54, 95% confidence interval = 0.41–0.72, P = 0.0001). There was an obvious effect of MMP2-1306 genotype on lung cancer risk among the subpopulations of ever smokers but not nonsmokers. As for the genotypes of MMP2-735, there was no such differential distribution in the aspects of genotypic or allelic frequencies, or combinative effects with smoking status. The genotypes of MMP2-1306 may act as a biomarker in determining personal susceptibility to lung cancer in Taiwan. The contribution of MMP2 genotypes alone and its joint effects with personal cigarette smoking habit on lung cancer susceptibility should be taken into consideration of the clinical practices for early detection and prediction of lung cancer in Taiwan.


How to cite this article:
Chen GL, Wang SC, Shen TC, Tsai CW, Chang WS, Li HT, Wu CN, Chao CY, Hsia TC, Bau DT. The association of matrix metalloproteinas-2 promoter polymorphisms with lung cancer susceptibility in Taiwan.Chin J Physiol 2019;62:210-216


How to cite this URL:
Chen GL, Wang SC, Shen TC, Tsai CW, Chang WS, Li HT, Wu CN, Chao CY, Hsia TC, Bau DT. The association of matrix metalloproteinas-2 promoter polymorphisms with lung cancer susceptibility in Taiwan. Chin J Physiol [serial online] 2019 [cited 2020 Nov 29 ];62:210-216
Available from: https://www.cjphysiology.org/article.asp?issn=0304-4920;year=2019;volume=62;issue=5;spage=210;epage=216;aulast=Chen;type=0